Choate recently represented Symbiotix Biotherapies, Inc. (Symbiotix), a pioneering venture-backed biotechnology company developing novel molecular therapeutics derived from the human microbiome, in negotiating its exclusive license…
Symbiotix Biotherapies’s exclusive license agreement with Harvard University
![](https://globallegalchronicle.com/wp-content/uploads/2018/04/e2f37697db.jpeg)